Dr. Ki Wook Kim On Developing Vaccines To Prevent Type 1 Diabetes
“The ultimate goal is to help develop vaccines to prevent T1D, as well as antiviral therapeutics to potentially treat people already diagnosed with T1D”
Dr Kim’s work aims to uncover the link between viruses and type 1 diabetes (T1D).
As one of the lead investigators of ENDIA, Dr Kim is looking at whether early infection by viruses during pregnancy and infancy increases the risk of developing T1D. ENDIA is a nationwide study involving 1,500 mothers and infants with a first degree relative with T1D. Dr Kim is looking at all the viruses women are exposed to during pregnancy, to see if this affects the chance of their child developing T1D.
When asked about how his research can help people, Dr Kim says the “ultimate goal is to help develop vaccines to prevent T1D, as well as antiviral therapeutics to potentially treat people already diagnosed with T1D”. By finding which specific types of viruses are associated with the development of T1D, researchers will have a better idea of where to focus their efforts for vaccine development. It could be the first vaccine in the world available for T1D!
“With technology and medicine advancing more rapidly than ever, there is enormous potential for earlier detection of individuals at risk of T1D…”
Dr. Kim is hopeful when asked about what to expect in future treatments and technology for people living with T1D. He says ‘with technology and medicine advancing more rapidly than ever, there is enormous potential for earlier detection of individuals at risk of T1D…’ Leading back to his research, he says ‘This early detection gives us the opportunity to intervene, including by preventing viral causes of T1D through the use of vaccines and antiviral drugs – which I feel that we’re really at the cusp of achieving!’.
“I would also like to emphasise that high quality research takes time and persistence.”
While there are promising breakthroughs on the horizon, continued funding and support is crucial for areas of research such as Dr. Kim’s. He says “I would also like to emphasise that high quality research takes time and persistence. This is why having continued support each year is so important to sustain the important research that we do.”
To learn more exciting research updates, T1D stories from the community and fundraising initiatives you can get involved in, sign up to our monthly newsletter and join the community!
Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop
Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
Fiasp insulin to remain on the Pharmaceutical Benefits Scheme
MEDIA RELEASE Fiasp insulin to remain on the Pharmaceutical Benefits Scheme The new listing of Fiasp® Penfill® on the Pharmaceutical Benefits Scheme will keep the life-saving medication available to the 15,000+ Australians who rely on it Sydney, 18 September 2023: JDRF Australia is welcoming an announcement from Minister for Health, Hon Mark Butler, that Fiasp […]
Type 1 diabetes and women’s health: periods and menopause
We all know how powerful hormones can be in controlling menstrual cycles, so it’s no surprise that they can also affect blood glucose levels. This can also make life a bit more challenging for women living with type 1 diabetes (T1D). In our book for adults living with T1D, Straight to the Point, we look […]
Support for siblings of children living with type 1 diabetes
If you have experience with type 1 diabetes (T1D), you’ll know that it can affect the whole family. And siblings of a child living with T1D can also be impacted by their brother or sister’s diagnosis. Although they’re not the ones being treated for T1D, siblings can be significantly impacted in lots of other ways. […]